Using immunohistochemistry and immunoblotting, the mTOR pathway was implicated in the pathobiological profiles of 150 lung carcinoma specimens and this was correlated with the downstream and upstream proteins p70S6-kinase (S6K) and Akt, respectively. This evidence concerns the gene AKT1 and lung carcinoma.